# SLFN13

## Overview
SLFN13 is a gene that encodes the protein schlafen family member 13, which is part of the schlafen protein family known for its involvement in RNA processing and translation regulation. The protein is characterized by its unique structural domains, including an N-domain with endoribonuclease activity and a C-domain homologous to superfamily I RNA/DNA helicases, suggesting roles in nucleic acid metabolism (Jo2022Structural). SLFN13 is primarily localized in the cytoplasm and is implicated in various biological processes, such as antiproliferation, cell differentiation, and inhibition of viral replication (Chen2019Deciphering). It plays a significant role in immune responses, particularly in maintaining T cells in a non-activated state (Xu2022Schlafen). Clinically, SLFN13 is associated with cancer progression and prognosis, as well as antiviral activity, particularly against HIV (Xu2022Schlafen; Yang2018Structure).

## Structure
SLFN13 is a member of the schlafen protein family, characterized by its unique molecular structure. The primary structure of SLFN13 includes a sequence that forms distinct domains: the N-domain, M-domain, and C-domain. The N-domain functions as an endoribonuclease, showing activity against rRNA and ribosome-associated mRNAs. It consists of two lobes, the N-lobe and C-lobe, and includes a conserved active site with residues Glu-Glu-Asp (EED) crucial for ribonuclease activity (Jo2022Structural). The N-domain has a U-shaped architecture, with a central four-stranded β-sheet surrounded by α-helices, and binds nucleotides via a positively charged patch (Yang2018Structure).

The tertiary structure of SLFN13 reveals a pseudo-dimeric U-pillow-shaped configuration, which allows the protein to dock base-paired RNAs. This structure is essential for its function in cleaving tRNA and rRNA, specifically at the acceptor stem of mature tRNAs (Yang2018Structure). The C-domain of SLFN13 is a putative helicase/ATPase domain, bearing homology to superfamily I RNA/DNA helicases, and includes a zinc finger motif that may assist in nucleotide recognition or protein folding (Jo2022Structural). The protein's quaternary structure is not explicitly detailed, but the presence of a zinc finger motif suggests potential dimerization or interaction with other proteins (Yang2018Structure).

## Function
SLFN13, a member of the schlafen protein family, plays a significant role in RNA processing and translation regulation. It possesses an N-domain with endoribonuclease activity, which allows it to cleave the acceptor stem of tRNAs, suggesting that it recognizes specific RNA structures. This activity implies that SLFN13 may modulate translation by targeting specific RNA structures, potentially impacting protein synthesis (Jo2022Structural). The C-domain of SLFN13 is homologous to superfamily I RNA/DNA helicases, indicating potential roles in nucleic acid metabolism (Jo2022Structural). 

SLFN13 is primarily localized in the cytoplasm, where it may interact with nucleic acids or functional cofactors through its M-domain, influencing its RNA cleavage activity (Jo2022Structural). The protein is involved in antiproliferation, cell differentiation, and inhibition of viral replication, although the precise biological implications of its RNA cleavage activity are not fully understood (Chen2019Deciphering). 

In the context of immune responses, SLFN13 is overexpressed in NK cells and is downregulated following T cell activation, suggesting a role in maintaining T cells in a non-activated state (Xu2022Schlafen).

## Clinical Significance
SLFN13 has been implicated in various diseases, particularly in the context of cancer. In gastric cancer, SLFN13 is overexpressed in tumor tissues compared to normal tissues, and its high expression is associated with poor prognosis, including reduced overall survival and progression-free survival. This suggests that SLFN13 may play a role in tumor progression and could serve as a prognostic indicator in gastric cancer patients (Xu2022Schlafen). 

SLFN13 is also involved in other malignancies, showing upregulation in pancreatic and renal cell carcinoma, while being downregulated in breast cancer, lung squamous carcinoma, prostate cancer, and rectal carcinoma. Its expression levels correlate negatively with survival outcomes when upregulated, indicating its potential role in cancer progression and prognosis (AlMarsoummi2021Schlafens:). 

In the context of viral infections, SLFN13 exhibits nucleolytic activity that restricts HIV replication by inhibiting viral protein synthesis, highlighting its potential as an antiviral agent. However, it does not significantly restrict other viruses like herpes simplex virus and only moderately restricts Zika virus (Yang2018Structure). 

Overall, SLFN13's expression and activity are linked to various clinical outcomes, particularly in cancer and viral infections, suggesting its potential as a therapeutic target.

## Interactions
SLFN13, a member of the Schlafen family, is primarily known for its interactions with nucleic acids, particularly tRNA and rRNA. It functions as a tRNA/rRNA-targeting endoribonuclease, cleaving these molecules to inhibit protein synthesis. This activity is crucial for its role in restricting HIV replication by reducing viral protein synthesis and the number of released viral particles (Yang2018Structure). SLFN13's nucleolytic activity is dependent on the presence of Mn2+/Mg2+ ions and is facilitated by specific charged residues within its structure, which are essential for its catalytic function (Yang2018Structure).

SLFN13 exhibits a unique pseudo-dimeric U-pillow-shaped architecture that allows it to dock base-paired RNA, recognizing secondary or tertiary structures rather than specific sequences (Yang2018Structure). This structural feature enables SLFN13 to cleave the acceptor stem of mature tRNAs, a specificity that distinguishes it from other eukaryotic endoribonucleases (Yang2018Structure).

While SLFN13's interactions with other proteins are not extensively detailed, its role in translational control and viral restriction suggests potential interactions with components of the translational machinery and viral elements, although these interactions require further investigation (Yang2018Structure; AlMarsoummi2021Schlafens:).


## References


[1. (Chen2019Deciphering) Jiaxing Chen and Leslie A. Kuhn. Deciphering the three-domain architecture in schlafens and the structures and roles of human schlafen12 and serpinb12 in transcriptional regulation. Journal of Molecular Graphics and Modelling, 90:59–76, July 2019. URL: http://dx.doi.org/10.1016/j.jmgm.2019.04.003, doi:10.1016/j.jmgm.2019.04.003. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.jmgm.2019.04.003)

[2. (Jo2022Structural) Ukhyun Jo and Yves Pommier. Structural, molecular, and functional insights into schlafen proteins. Experimental &amp; Molecular Medicine, 54(6):730–738, June 2022. URL: http://dx.doi.org/10.1038/s12276-022-00794-0, doi:10.1038/s12276-022-00794-0. This article has 30 citations.](https://doi.org/10.1038/s12276-022-00794-0)

[3. (Xu2022Schlafen) Jiannan Xu, Songyao Chen, Jianming Liang, Tengfei Hao, Huabin Wang, Guangyao Liu, Xinghan Jin, Huan Li, Junchang Zhang, Changhua Zhang, and Yulong He. Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer. Frontiers in Immunology, August 2022. URL: http://dx.doi.org/10.3389/fimmu.2022.922138, doi:10.3389/fimmu.2022.922138. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2022.922138)

[4. (AlMarsoummi2021Schlafens:) Sarmad Al-Marsoummi, Emilie E. Vomhof-DeKrey, and Marc D. Basson. Schlafens: emerging proteins in cancer cell biology. Cells, 10(9):2238, August 2021. URL: http://dx.doi.org/10.3390/cells10092238, doi:10.3390/cells10092238. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells10092238)

[5. (Yang2018Structure) Jin-Yu Yang, Xiang-Yu Deng, Yi-Sheng Li, Xian-Cai Ma, Jian-Xiong Feng, Bing Yu, Yang Chen, Yi-Ling Luo, Xi Wang, Mei-Ling Chen, Zhi-Xin Fang, Fu-Xiang Zheng, Yi-Ping Li, Qian Zhong, Tie-Bang Kang, Li-Bing Song, Rui-Hua Xu, Mu-Sheng Zeng, Wei Chen, Hui Zhang, Wei Xie, and Song Gao. Structure of schlafen13 reveals a new class of trna/rrna- targeting rnase engaged in translational control. Nature Communications, March 2018. URL: http://dx.doi.org/10.1038/s41467-018-03544-x, doi:10.1038/s41467-018-03544-x. This article has 89 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-018-03544-x)